ArticleJournal of neuro-oncology2022

Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study.

Amir Massarweh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.